期刊文献+

黄芪加血府逐瘀汤加减治疗气虚血瘀型急性脑梗死的临床疗效及安全性 被引量:6

Clinical effect and the safety of astragalus membranaceus with xuefu zhuyu decoction modified in treating acute cerebral infarction
原文传递
导出
摘要 目的探讨黄芪加血府逐瘀汤加减治疗气虚血瘀型急性脑梗死的临床疗效及安全性。方法选取射阳县通洋中心卫生院2014年1月—2016年9月收治的气虚血瘀型急性脑梗死患者65例,按照随机数字表法分为对照组32例和观察组33例。对照组患者采用西医常规对症治疗,观察组患者在对照组基础上给予黄芪加血府逐瘀汤加减治疗,两组患者均持续治疗3个疗程。比较两组患者治疗前后中医症候积分及美国国立卫生研究院卒中量表(NIHSS)评分、临床疗效,观察患者不良反应发生情况。结果治疗前,两组患者中医症候积分、NIHSS评分比较,差异无统计学意义(P>0.05);治疗后,观察组患者中医症候积分、NIHSS评分低于对照组(P<0.05)。观察组患者治疗总有效率高于对照组(P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论采用黄芪加血府逐瘀汤加减治疗气虚血瘀证急性脑梗死的临床疗效确切,可有效改善患者的神经功能,缓解临床症状,且安全性好。 Objective To investigate the clinical effect and the safety of astragalus membranaceus with xuefu zhuyu decoction modified in treating acute cerebral infarction. Methods A total of 65 cases of acute cerebral infarction patients were selected from January 2014 to September 2016 in Sheyang County Tong Yang Central Hospital,which were divided into control group( n = 32) and observation group( n = 33). Control group was given conventional western medicine,observation group was treated with astragalus membranaceus with xuefu zhuyu decoction modified based on control group,both groups were treated for 3 courses. The TCM symptom scores and NIHSS scores before and after treatment,clinical effect were compared between the two groups,and the incidence of adverse reactions were observed of patients. Results Before treatment,no statistically significant differences of TCM symptom scores or NIHSS scores was found between the two groups( P〉0. 05); after treatment,the observation group of TCM symptom scores and NHISS scores were lower than control group( P〈0. 05). The total effective rate of observation group was higher than control group( P〈0. 05). There was no statistically significant difference of adverse reaction rate between the two groups( P〉0. 05). Conclusion Astragalus membranaceus with xuefu zhuyu decoction modified haven an exactly clinical effect in treating acute cerebral infarction,it can effectively improve neurologic function of patients,relieve clinical symptoms,and with good safety.
作者 蔡杰
出处 《临床合理用药杂志》 2017年第21期14-15,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 脑梗死 血府逐瘀汤 黄芪 治疗结果 安全性 Brain infarction Xuefu zhuyu decoction Astragalus membranaceus Treatment outcome Safety
  • 相关文献

参考文献6

二级参考文献47

  • 1中风病诊断与疗效评定标准(试行)[J].北京中医药大学学报,1996,19(1):55-56. 被引量:6003
  • 2毕胜,纪树荣,顾越,瓮长水.Fugl-Meyer上肢运动功能评分与上肢运动功能状态评分的响应性研究[J].中国康复医学杂志,2006,21(2):118-120. 被引量:134
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33029
  • 4刘西华.血府逐瘀汤在近代医学中应用.福建中医药,1988,19:58-60.
  • 5郑筱萸.中药新药临床研究指导原则[S].北京:中国医药科技出版杜,2002.
  • 6国家中医药管理局脑病急症协作组.中风病诊断与疗效评定标准[S].北京中医药大学学报,2009,19(1):55.
  • 7刘西华.血府逐瘀汤在近代医学中应用[J].福建中医药,2008,19:58-60.
  • 8程俊敏.加减血府逐瘀汤治疗急性糖尿病性脑梗塞的临床研究[J].湖北中医学院,2012,24(6):427-429.
  • 9戴孟,孙玉周.疏血通治疗急性糖尿病性脑梗塞及对血液流变学的影响[J].中药材,2014,26(15):516-518.
  • 10臧召霞,刘永丹,刘志强,等.加减血府逐瘀汤治疗急性脑梗死患者的临床疗效[J].中国药物经济学,2012,25(9):351-353.

共引文献68

同被引文献44

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部